U063 Steroid Side Effects for Dermatologists: What a Practicing Clinician Needs to Know in a Fast-paced Clinic
DESCRIPTION
This session will provide dermatologists with high-yield tips to effectively and efficiently manage steroid side effects in fast-paced dermatology clinics. This session will cover initiation of therapy, osteoporosis, infectious complications, and endocrine and GI complications.
LEARNING OBJECTIVES
Predict what side effects are most likely to impact patients when starting therapy with systemic glucocorticoids; Outline steps that can be taken at the outset to proactively address these side effects and implement protective measures for bone health.
Recognize that glucocorticoid use increases risk for infections; Assess risk factors for particular infectious complications including pneumocystis pneumonia and demonstrate knowledge of when to start PJP prophylaxis.
Describe glucocorticoid dosing regimens that increase risk for adrenal insufficiency, and utilize tapering methods to reduce the risk for steroid withdrawal on cessation of therapy; Select preventative measures for reducing risk for peptic ulcer disease and GI bleed.
SCHEDULE
7:00 AM
Introduction to steroid side effects
Avrom Caplan, MD, FAAD
7:05 AM
Glucocorticoid induced osteoporosis, a Summary for dermatologists
Avrom Caplan, MD, FAAD
7:20 AM
Infections and Prophylaxis in Patients on Glucocorticoids
Robert Micheletti, MD, FAAD
7:35 AM
Endocrine, Gastric, and Assorted Steroid Side Effects
Victoria P. Werth, MD, FAAD
7:50 AM
Question and Answer
DIRECTOR
Avrom Caplan, MD, FAAD
SPEAKERS
Robert Micheletti, MD, FAAD
Victoria P. Werth, MD, FAAD
HANDOUTS
DISCLOSURES
Avrom Caplan, MD, FAAD
Novartis – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Robert Micheletti, MD, FAAD
Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arionix – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Daiichi Sanko – Consultant (1099 relationship)(Honoraria); Dianthus Therapeutics – Consultant (1099 relationship)(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Innovaderm Research Inc. – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Prolium – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Valuence – Consultant (1099 relationship)(Honoraria); Vindico Medical Education – Speaker/Faculty Education(Honoraria);